该病例报告说明了一名3个月大的川崎病婴儿的严重临床病程,众所周知,年幼的婴儿对川崎病特异性治疗反应不佳,并会出现严重的疾病进展。他们也更有可能表现为复发性炎症。尽管早期接受了基于指南的治疗,但该婴儿仍发展为巨大的冠状动脉瘤。关于这个微妙的年龄组的治疗值得更深入的研究和讨论,这些患儿将来可能会从特定的治疗建议中受益。 参考文献:[1]Lersch R, Mandilaras G, Schrader M, Anselmino F, Haas NA, Jakob A. Have we got the optimal treatment for refractory Kawasaki disease in very young infants? A case report and literature review. Front Pediatr. 2023 Jul 28;11:1210940. doi: 10.3389/fped.2023.1210940. PMID: 37576144; PMCID: PMC10419265.[2]McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation. (2017) 135(17):e927–99. doi: 10.1161/CIR.0000000000000484[3]McCrindle BW, Li JS, Minich LL, Colan SD, Atz AM, Takahashi M, et al. Coronary artery involvement in children with Kawasaki disease: risk factors from analysis of serial normalized measurements. Circulation. (2007)116(2):174–9. doi: 10.1161/CIRCULATIONAHA.107.690875